Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Surgically Treated
100%
Postoperative Radiotherapy
100%
Overall Survival
87%
Recurrence-free Survival
75%
Hazard Ratio
62%
Radiotherapy
37%
Patient Characteristics
25%
Stage II-III
25%
Treatment Duration
25%
Advanced Stage Disease
25%
Worse Outcome
12%
Disease Factor
12%
Advanced Disease
12%
Retrospective Review
12%
Academic Medical Centers
12%
Tumor Characteristics
12%
Subgroup Analysis
12%
Time-to-treatment
12%
Prolonged Treatment
12%
Oropharyngeal
12%
Optimal Timing
12%
Stage Group
12%
American Joint Committee on Cancer
12%
Eighth Edition
12%
Locoregionally Advanced
12%
Initiation Interval
12%
Day Surgery
12%
Medicine and Dentistry
Wart Virus
100%
Oropharynx Squamous Cell Carcinoma
100%
Radiation Therapy
100%
Overall Survival
63%
Recurrence Free Survival
54%
Diseases
54%
Hazard Ratio
45%
Recurrent Disease
27%
Malignant Neoplasm
9%
Neoplasm
9%
Subgroup Analysis
9%
Ambulatory Surgery
9%
Human Papillomavirus Related Disease
9%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Human Papillomavirus
100%
Oropharynx Squamous Cell Carcinoma
100%
Diseases
100%
Recurrence Free Survival
85%
Recurrent Disease
42%
Neoplasm
14%
Malignant Neoplasm
14%